ANAVEX LIFE SCIENCES CORP. Interest Income (Expense), Net
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Interest Income (Expense), Net of $1.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. interest income (expense), net for the quarter ending 2026-06-30 was $1.07M, a 0.28% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. interest income (expense), net for the quarter ending 2026-03-31 was $1.06M, a 12.31% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. interest income (expense), net for the quarter ending 2025-12-31 was $1.08M, a 22.60% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. interest income (expense), net for the quarter ending 2025-09-30 was $999.00K, a 43.21% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. interest income (expense), net for fiscal 2025 was $4.68M, a 36.09% decline from fiscal 2024.
- ANAVEX LIFE SCIENCES CORP. interest income (expense), net for fiscal 2024 was $7.32M, a 12.29% increase from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. interest income (expense), net for fiscal 2023 was $6.52M, a 588.38% increase from fiscal 2022.
- ANAVEX LIFE SCIENCES CORP. interest income (expense), net for fiscal 2022 was $947.00K, a 3542.31% increase from fiscal 2021.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 3 month as first filed | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 6 month as first filed | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 9 month as first filed | Interest Income (Expense), Net 12 month | Interest Income (Expense), Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.07M 10-Q · filed 2026-08-28 | $2.13M derived: sum of 2 quarters · filed 2026-08-28 | $3.21M 10-Q · filed 2026-08-28 | $4.21M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2026-03-31 | $1.06M 10-Q · filed 2026-08-28 | $2.14M 10-Q · filed 2026-08-28 | $3.14M derived: sum of 3 quarters · filed 2026-08-28 | $4.21M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | $1.08M 10-Q · filed 2026-02-09 | $2.08M derived: sum of 2 quarters · filed 2026-08-28 | $3.15M derived: sum of 3 quarters · filed 2026-08-28 | $4.36M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-09-30 | $999.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $2.07M derived: sum of 2 quarters · filed 2026-08-28 | $3.28M derived: sum of 3 quarters · filed 2026-08-28 | $4.68M 10-K/A · filed 2026-08-28 | ||||
| 2025-06-30 | $1.07M 10-Q · filed 2026-08-28 | $2.29M derived: sum of 2 quarters · filed 2026-08-28 | $3.68M 10-Q · filed 2026-08-28 | $5.44M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-03-31 | $1.21M 10-Q · filed 2026-08-28 | $2.60M 10-Q · filed 2026-08-28 | $4.36M derived: sum of 3 quarters · filed 2026-08-28 | $6.16M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-12-31 | $1.39M 10-Q · filed 2026-02-09 | $3.15M derived: sum of 2 quarters · filed 2026-08-28 | $4.95M derived: sum of 3 quarters · filed 2026-08-28 | $6.71M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-09-30 | $1.76M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $3.56M derived: sum of 2 quarters · filed 2026-08-28 | $5.31M derived: sum of 3 quarters · filed 2026-08-28 | $7.32M 10-K/A · filed 2026-08-28 | ||||
| 2024-06-30 | $1.80M 10-Q · filed 2025-08-12 | $3.55M derived: sum of 2 quarters · filed 2025-08-12 | $5.56M 10-Q · filed 2025-08-12 | $7.52M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-03-31 | $1.76M 10-Q · filed 2025-05-13 | $3.76M 10-Q · filed 2025-05-13 | $5.72M derived: sum of 3 quarters · filed 2026-08-28 | $7.55M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-12-31 | $2.01M 10-Q · filed 2025-02-12 | $3.97M derived: sum of 2 quarters · filed 2026-08-28 | $5.79M derived: sum of 3 quarters · filed 2026-08-28 | $7.26M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-09-30 | $1.96M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $3.79M derived: sum of 2 quarters · filed 2026-08-28 | $5.25M derived: sum of 3 quarters · filed 2026-08-28 | $6.52M 10-K/A · filed 2026-08-28 | ||||
| 2023-06-30 | $1.83M 10-Q · filed 2024-08-06 | $1.83M 10-Q · filed 2023-08-08 | $3.29M derived: sum of 2 quarters · filed 2024-08-06 | $4.56M 10-Q · filed 2024-08-06 | $4.56M 10-Q · filed 2023-08-08 | $5.27M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $1.47M 10-Q · filed 2024-05-09 | $1.47M 10-Q · filed 2023-05-09 | $2.73M 10-Q · filed 2024-05-09 | $2.73M 10-Q · filed 2023-05-09 | $3.44M derived: sum of 3 quarters · filed 2024-05-09 | $3.67M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $1.27M 10-Q · filed 2024-02-07 | $1.27M 10-Q · filed 2023-02-07 | $1.97M derived: sum of 2 quarters · filed 2024-02-07 | $2.20M derived: sum of 3 quarters · filed 2024-02-07 | $2.21M derived: sum of 4 quarters · filed 2024-02-07 | |||
| 2022-09-30 | $704.60K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $934.51K derived: sum of 2 quarters · filed 2023-11-27 | $942.09K derived: sum of 3 quarters · filed 2023-11-27 | $947.00K 10-K · filed 2023-11-27 | $946.99K 10-K · filed 2022-11-28 | |||
| 2022-06-30 | $229.92K 10-Q · filed 2023-08-08 | $237.50K derived: sum of 2 quarters · filed 2023-08-08 | $242.41K 10-Q · filed 2023-08-08 | $249.29K derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2022-03-31 | $7.58K 10-Q · filed 2023-05-09 | $12.49K 10-Q · filed 2023-05-09 | $19.38K derived: sum of 3 quarters · filed 2023-11-27 | $30.83K derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2021-12-31 | $4.91K 10-Q · filed 2023-02-07 | $11.80K derived: sum of 2 quarters · filed 2023-11-27 | $23.25K derived: sum of 3 quarters · filed 2023-11-27 | $32.47K derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2021-09-30 | $6.89K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $18.34K derived: sum of 2 quarters · filed 2023-11-27 | $27.56K derived: sum of 3 quarters · filed 2023-11-27 | $26.00K 10-K · filed 2023-11-27 | $26.26K 10-K · filed 2021-11-24 | |||
| 2021-06-30 | $11.45K 10-Q · filed 2022-08-09 | $20.67K derived: sum of 2 quarters · filed 2022-08-09 | $19.11K 10-Q · filed 2022-08-09 | $26.09K derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2021-03-31 | $9.22K 10-Q · filed 2022-05-10 | $7.66K 10-Q · filed 2022-05-10 | $14.63K derived: sum of 3 quarters · filed 2022-11-28 | $70.73K derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-12-31 | -$1.56K 10-Q · filed 2022-02-09 | $5.42K derived: sum of 2 quarters · filed 2022-11-28 | $61.51K derived: sum of 3 quarters · filed 2022-11-28 | $131.69K derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-09-30 | $6.98K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $63.07K derived: sum of 2 quarters · filed 2022-11-28 | $133.25K derived: sum of 3 quarters · filed 2022-11-28 | $179.97K 10-K · filed 2022-11-28 | ||||
| 2020-06-30 | $56.10K 10-Q · filed 2021-08-12 | $126.28K derived: sum of 2 quarters · filed 2021-08-12 | $173.00K 10-Q · filed 2021-08-12 | $215.17K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $70.18K 10-Q · filed 2021-05-13 | $116.90K 10-Q · filed 2021-05-13 | $159.08K derived: sum of 3 quarters · filed 2021-05-13 | $193.91K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $46.72K 10-Q · filed 2021-02-16 | $88.90K derived: sum of 2 quarters · filed 2021-02-16 | $123.73K derived: sum of 3 quarters · filed 2021-02-16 | $175.20K derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | $42.18K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $77.02K derived: sum of 2 quarters · filed 2020-12-28 | $128.48K derived: sum of 3 quarters · filed 2020-12-28 | $207.28K 10-K · filed 2020-12-28 | ||||
| 2019-06-30 | $34.84K 10-Q · filed 2020-08-06 | $86.30K derived: sum of 2 quarters · filed 2020-08-06 | $165.10K 10-Q · filed 2020-08-06 | $248.95K derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $51.47K 10-Q · filed 2020-05-07 | $130.26K 10-Q · filed 2020-05-07 | $214.11K derived: sum of 3 quarters · filed 2020-05-07 | $326.33K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $78.80K 10-Q · filed 2020-02-06 | $162.64K derived: sum of 2 quarters · filed 2020-02-06 | $274.87K derived: sum of 3 quarters · filed 2020-02-06 | $303.52K derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-09-30 | $83.84K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $196.07K derived: sum of 2 quarters · filed 2019-12-16 | $224.72K derived: sum of 3 quarters · filed 2019-12-16 | $255.09K 10-K · filed 2019-12-16 | ||||
| 2018-06-30 | $112.23K 10-Q · filed 2019-08-07 | $140.87K derived: sum of 2 quarters · filed 2019-08-07 | $171.25K 10-Q · filed 2019-08-07 | $210.87K derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $28.65K 10-Q · filed 2019-05-09 | $59.02K 10-Q · filed 2019-05-09 | $98.64K derived: sum of 3 quarters · filed 2019-05-09 | $125.32K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $30.38K 10-Q · filed 2019-02-07 | $70.00K derived: sum of 2 quarters · filed 2019-02-07 | $96.67K derived: sum of 3 quarters · filed 2019-02-07 | $114.82K derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-09-30 | $39.62K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $66.30K derived: sum of 2 quarters · filed 2019-01-25 | $84.44K derived: sum of 3 quarters · filed 2019-01-25 | $88.10K 10-K · filed 2019-01-25 | ||||
| 2017-06-30 | $26.68K 10-Q · filed 2018-08-09 | $44.82K derived: sum of 2 quarters · filed 2018-08-09 | $48.48K 10-Q · filed 2018-08-09 | $52.97K derived: sum of 4 quarters · filed 2019-01-25 | ||||
| 2017-03-31 | $18.15K 10-Q · filed 2018-05-10 | $21.80K 10-Q · filed 2018-05-10 | $26.29K derived: sum of 3 quarters · filed 2019-01-25 | $28.92K derived: sum of 4 quarters · filed 2019-01-25 | ||||
| 2016-12-31 | $3.65K 10-Q · filed 2018-02-07 | $8.14K derived: sum of 2 quarters · filed 2019-01-25 | $10.77K derived: sum of 3 quarters · filed 2019-01-25 | $12.84K derived: sum of 4 quarters · filed 2019-01-25 | ||||
| 2016-09-30 | $4.49K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $7.12K derived: sum of 2 quarters · filed 2019-01-25 | $9.18K derived: sum of 3 quarters · filed 2019-01-25 | $11.32K 10-K · filed 2019-01-25 | ||||
| 2016-06-30 | $2.63K 10-Q · filed 2017-08-07 | $4.69K derived: sum of 2 quarters · filed 2017-08-07 | $6.83K 10-Q · filed 2017-08-07 | $8.53K derived: sum of 4 quarters · filed 2017-12-11 | ||||
| 2016-03-31 | $2.06K 10-Q · filed 2017-05-10 | $4.21K 10-Q · filed 2017-05-10 | $5.91K derived: sum of 3 quarters · filed 2017-12-11 | $7.16K derived: sum of 4 quarters · filed 2017-12-11 | ||||
| 2015-12-31 | $2.14K 10-Q · filed 2017-02-07 | $3.84K derived: sum of 2 quarters · filed 2017-12-11 | $5.10K derived: sum of 3 quarters · filed 2017-12-11 | |||||
| 2015-09-30 | $1.70K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $2.96K derived: sum of 2 quarters · filed 2017-12-11 | -$71.83K 10-K · filed 2017-12-11 | |||||
| 2015-06-30 | $1.25K 10-Q · filed 2016-08-11 | -$73.53K 10-Q · filed 2016-08-11 | ||||||
| 2014-09-30 | $9.77K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | $1.28K derived: sum of 2 quarters · filed 2016-12-14 | -$7.09K 10-K · filed 2016-12-14 | |||||
| 2014-06-30 | -$8.49K 10-Q · filed 2015-08-14 | -$16.86K 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |